ATARA BIOTHERAPEUTICS INC's ticker is and the CUSIP is 046513907. A total of 3 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $395,012 | -41.4% | 266,900 | -36.3% | 0.00% | -50.0% |
Q2 2023 | $674,268 | -62.9% | 418,800 | -33.2% | 0.00% | -71.4% |
Q1 2023 | $1,818,590 | -25.0% | 627,100 | -15.2% | 0.01% | +16.7% |
Q4 2022 | $2,425,560 | +15059.8% | 739,500 | +17507.1% | 0.01% | – |
Q3 2022 | $16,000 | -83.5% | 4,200 | -66.1% | 0.00% | – |
Q2 2022 | $97,000 | -58.0% | 12,400 | -50.2% | 0.00% | – |
Q1 2022 | $231,000 | +126.5% | 24,900 | +283.1% | 0.00% | – |
Q4 2021 | $102,000 | -50.0% | 6,500 | -43.0% | 0.00% | – |
Q3 2021 | $204,000 | +251.7% | 11,400 | +208.1% | 0.00% | – |
Q2 2021 | $58,000 | -38.9% | 3,700 | -43.9% | 0.00% | – |
Q1 2021 | $95,000 | -71.0% | 6,600 | -60.5% | 0.00% | -100.0% |
Q4 2020 | $328,000 | +38.4% | 16,700 | -8.7% | 0.00% | 0.0% |
Q3 2020 | $237,000 | +24.1% | 18,300 | +39.7% | 0.00% | 0.0% |
Q2 2020 | $191,000 | +122.1% | 13,100 | +29.7% | 0.00% | 0.0% |
Q1 2020 | $86,000 | -78.5% | 10,100 | -58.4% | 0.00% | -66.7% |
Q4 2019 | $400,000 | +5.0% | 24,300 | -10.0% | 0.00% | 0.0% |
Q3 2019 | $381,000 | -4.3% | 27,000 | +36.4% | 0.00% | -25.0% |
Q2 2019 | $398,000 | +20.2% | 19,800 | +147.5% | 0.00% | +33.3% |
Q3 2018 | $331,000 | +12.6% | 8,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $294,000 | +398.3% | 8,000 | +433.3% | 0.00% | +200.0% |
Q1 2018 | $59,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 3,700 | $58,000 | 0.00% |
SIMPLEX TRADING, LLC | 600 | $9,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |